{"transactions":[{"id":1461369,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":89210,"kind":"person","name":"BAILEY DON M","position":1,"cik":"0001223697","reported_name":"BAILEY DON M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-03T21:00:08.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest and become exercisable on July 1, 2025, subject to the reporting person's continuous service with the issuer."}],"balance_after":75000,"derivative":{"exercise_price":0.9541,"expiration_date":"2034-07-01","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000950170-24-081605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000095017024081605/ownership.xml","form_type":"4"}},{"id":1654313,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":89210,"kind":"person","name":"BAILEY DON M","position":1,"cik":"0001223697","reported_name":"BAILEY DON M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, no par value","published_at":"2024-02-09T00:00:09.000Z","date":"2024-02-08","kind":"purchase","planned":false,"acquired":true,"shares":96155,"price":1.04,"value":100001.2,"ownership":{"direct":false,"nature":"By The Bailey Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include common shares that may be acquired upon the exercise of stock options outstanding as of the date of this report."}],"balance_after":158801,"source":{"system":"sec-edgar","filing":"0001493152-24-005510","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315224005510/ownership.xml","form_type":"4"}},{"id":1840352,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":89210,"kind":"person","name":"BAILEY DON M","position":1,"cik":"0001223697","reported_name":"BAILEY DON M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-03T21:46:12.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest and become exercisable on July 1, 2024, subject to the reporting person's continuous service with the issuer."}],"balance_after":50000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-07-01","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-23-023344","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315223023344/ownership.xml","form_type":"4"}},{"id":2213195,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":89210,"kind":"person","name":"BAILEY DON M","position":1,"cik":"0001223697","reported_name":"BAILEY DON M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-06T20:15:42.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest and become exercisable on July 1, 2023, subject to the reporting person's continuous service with the issuer."}],"balance_after":50000,"derivative":{"exercise_price":1.57,"expiration_date":"2032-07-01","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-018680","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222018680/ownership.xml","form_type":"4"}},{"id":2648701,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":89210,"kind":"person","name":"BAILEY DON M","position":1,"cik":"0001223697","reported_name":"BAILEY DON M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-01T22:32:07.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest and become exercisable on July 1, 2022, subject to the reporting person's continuous service with the issuer."}],"balance_after":50000,"derivative":{"exercise_price":2.86,"expiration_date":"2031-07-01","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-21-015892","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221015892/ownership.xml","form_type":"4"}},{"id":3093737,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":89210,"kind":"person","name":"BAILEY DON M","position":1,"cik":"0001223697","reported_name":"BAILEY DON M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T21:03:39.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will become exercisable on July 1, 2021, based upon continued service on the board of directors."}],"balance_after":40000,"derivative":{"exercise_price":0.8263,"expiration_date":"2030-07-01","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-20-012538","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220012538/ownership.xml","form_type":"4"}},{"id":3469443,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":89210,"kind":"person","name":"BAILEY DON M","position":1,"cik":"0001223697","reported_name":"BAILEY DON M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-04T01:22:27.000Z","date":"2019-03-19","kind":"grant","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will become exercisable on March 19, 2020, based upon continued service on the board of directors."}],"balance_after":60000,"derivative":{"exercise_price":1.57,"expiration_date":"2029-03-18","underlying":"Common Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-19-041312","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919119041312/doc4.xml","form_type":"4"}},{"id":3469442,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":89210,"kind":"person","name":"BAILEY DON M","position":1,"cik":"0001223697","reported_name":"BAILEY DON M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-04T01:22:27.000Z","date":"2019-07-01","kind":"grant","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will become exercisable on June 30, 2020, based upon continued service on the board of directors."}],"balance_after":40000,"derivative":{"exercise_price":1.03,"expiration_date":"2029-06-30","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-19-041312","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919119041312/doc4.xml","form_type":"4"}},{"id":3883916,"issuer":{"id":159180,"kind":"organization","name":"Asterias Biotherapeutics, Inc.","symbol":"NONE"},"owners":[{"id":89210,"kind":"person","name":"BAILEY DON M","position":1,"cik":"0001223697","reported_name":"BAILEY DON M","relationship":{"director":true}}],"security":"Stock Options","published_at":"2018-06-25T16:40:02.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest equally over the next four quarters, beginning on the June 30, 2018 contingent upon continued service on the Board of Directors."}],"balance_after":75000,"derivative":{"exercise_price":1.75,"expiration_date":"2028-06-21","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001140361-18-029801","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1223697/000114036118029801/form4.xml","form_type":"4"}},{"id":4277229,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":89210,"kind":"person","name":"BAILEY DON M","position":1,"cik":"0001223697","reported_name":"BAILEY DON M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-06-19T21:17:51.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Will become exercisable in four equal installments on September 30, 2017, December 31, 2017, March 31, 2018, and one day before the Company's next annual meeting of shareholders, based upon continued service on the board of directors from the date of grant on June 15, 2017."}],"balance_after":20000,"derivative":{"exercise_price":5.1,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-17-040978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1223697/000120919117040978/doc4.xml","form_type":"4"}},{"id":4277228,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":89210,"kind":"person","name":"BAILEY DON M","position":1,"cik":"0001223697","reported_name":"BAILEY DON M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-06-19T21:17:51.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":6520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Options are granted to directors annually. These options are a \"transitional grant\" reflecting the change in the date of the annual grant from February to the date of the annual meeting of shareholders. The options are 32.60% of the annual grant for the 119-day gap between February 16, 2017, one year from the last annual grant, and June 15, 2017, date of the full annual grant for 2017-2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Will become exercisable in four equal installments on September 30, 2017, December 31, 2017, March 31, 2018, and one day before the Company's next annual meeting of shareholders, based upon continued service on the board of directors from the date of grant on June 15, 2017."}],"balance_after":6520,"derivative":{"exercise_price":5.1,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":6520},"source":{"system":"sec-edgar","filing":"0001209191-17-040978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1223697/000120919117040978/doc4.xml","form_type":"4"}},{"id":4364924,"issuer":{"id":159180,"kind":"organization","name":"Asterias Biotherapeutics, Inc.","symbol":"NONE"},"owners":[{"id":89210,"kind":"person","name":"BAILEY DON M","position":1,"cik":"0001223697","reported_name":"BAILEY DON M","relationship":{"director":true}}],"security":"Stock Options","published_at":"2017-04-03T17:00:32.000Z","date":"2017-03-30","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock options vest over four equal quarterly installments beginning on March 31, 2017, contingent upon continued service on the Board of Directors."}],"balance_after":75000,"derivative":{"exercise_price":3.45,"exercise_date":"2017-03-30","expiration_date":"2027-03-29","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001140361-17-014409","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1223697/000114036117014409/form4.xml","form_type":"4"}},{"id":4577480,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":89210,"kind":"person","name":"BAILEY DON M","position":1,"cik":"0001223697","reported_name":"BAILEY DON M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2016-10-19T21:24:07.000Z","date":"2016-10-17","kind":"grant","acquired":true,"shares":230769,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These warrants became exercisable on October 17, 2016, the date shareholders approved the issuance of OncoCyte common stock upon exercise of the warrants, and may be exercised for five years from the date they became exercisable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These warrants became exercisable on October 17, 2016, the date shareholders approved the issuance of OncoCyte common stock upon exercise of the warrants, and may be exercised for five years from the date they became exercisable."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares are held by Mr. Bailey and his wife as co-trustees of a revocable trust, and in such capacity Mr. Bailey and his wife have shared voting and dispositive power over the shares."}],"balance_after":230769,"derivative":{"exercise_price":3.25,"underlying":"Common Stock","underlying_shares":230769},"source":{"system":"sec-edgar","filing":"0001209191-16-146423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1223697/000120919116146423/doc4.xml","form_type":"4"}}]}